CDH1 germline mutations and hereditary lobular breast cancer
- PMID: 26759166
- DOI: 10.1007/s10689-016-9869-5
CDH1 germline mutations and hereditary lobular breast cancer
Abstract
Hereditary diffuse gastric cancer is an autosomal dominant inherited disease associated of CDH1 germline mutations (that encodes for the E-cadherin protein), and lobular breast cancer is the second most frequent type of neoplasia. Recently, novel E-cadherin constitutional alterations have been identified in pedigree clustering only for lobular breast carcinoma without evidence of diffuse gastric tumors and in absence of BRCA1/2 mutations. This first evidence opens novel questions about the inherited correlation between diffuse gastric and lobular breast cancers. In this brief review we revise the literature data about the CDH1 mutation frequency affecting exclusively lobular breast cancer, providing clinical recommendation for asymptomatic mutation carriers.
Keywords: E-cadherin germline mutation; Hereditary breast cancer; Lobular breast cancer.
Similar articles
-
E-cadherin germline mutation carriers: clinical management and genetic implications.Cancer Metastasis Rev. 2014 Dec;33(4):1081-94. doi: 10.1007/s10555-014-9528-y. Cancer Metastasis Rev. 2014. PMID: 25332147 Review.
-
Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.Gastroenterology. 2015 Oct;149(4):897-906.e19. doi: 10.1053/j.gastro.2015.06.003. Epub 2015 Jun 11. Gastroenterology. 2015. PMID: 26072394
-
Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer.Cancer. 2011 Jul 15;117(14):3112-7. doi: 10.1002/cncr.25876. Epub 2011 Jan 26. Cancer. 2011. PMID: 21271559
-
Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect.J Med Genet. 2018 Jul;55(7):431-441. doi: 10.1136/jmedgenet-2018-105337. Epub 2018 Jun 21. J Med Genet. 2018. PMID: 29929997 Review.
-
Hereditary diffuse gastric and lobular breast cancer syndrome associated with germline CDH1 variants: focus on lobular breast cancer.J Cancer Res Clin Oncol. 2025 May 14;151(5):164. doi: 10.1007/s00432-025-06222-w. J Cancer Res Clin Oncol. 2025. PMID: 40366456 Free PMC article. Review.
Cited by
-
A Novel Attention-Mechanism Based Cox Survival Model by Exploiting Pan-Cancer Empirical Genomic Information.Cells. 2022 Apr 22;11(9):1421. doi: 10.3390/cells11091421. Cells. 2022. PMID: 35563727 Free PMC article.
-
Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.Genome Med. 2020 May 29;12(1):52. doi: 10.1186/s13073-020-00745-2. Genome Med. 2020. PMID: 32471470 Free PMC article.
-
Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.J Hematol Oncol. 2019 Apr 11;12(1):38. doi: 10.1186/s13045-019-0725-6. J Hematol Oncol. 2019. PMID: 30975222 Free PMC article. Review.
-
Gastric carcinoma: Insights into risk factors, methods of diagnosis, possible lines of management, and the role of primary care.J Family Med Prim Care. 2020 Jun 30;9(6):2659-2663. doi: 10.4103/jfmpc.jfmpc_527_20. eCollection 2020 Jun. J Family Med Prim Care. 2020. PMID: 32984103 Free PMC article. Review.
-
Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.BMC Cancer. 2021 Apr 7;21(1):363. doi: 10.1186/s12885-021-08089-9. BMC Cancer. 2021. PMID: 33827469 Free PMC article.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous